Anti-CD38

Pan-Pacific Guidelines for Anti-CD38 Therapy in Relapsed/Refractory Multiple Myeloma

A paper by Wenming Chen et al., published in Clinical Hematology International, was mentioned by Mohamad Mohty, Head of the Clinical Hematology and Cellular Therapy Department at Saint-Antoine Hospital, Sorbonne University, on X:

Title: Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group

Authors: Wenming Chen, Zhen Cai, Chor Sang Chim, Wee Joo Chng, Juan Du, Chengcheng Fu, Wen Gao, Ichiro Hanamura, Jian Hou, Jeffrey Shang-Yi Huang, Tadao Ishida, Chunrui Li, Aijun Liu, Vadim Ptushkin, Naoki Takezako, Raymond Siu Ming Wong, Dok Hyun Yoon

You can read the Full Article on Clinical Hematology International.

Pan-Pacific Guidelines for Anti-CD38 Therapy in Relapsed/Refractory Multiple Myeloma

More posts featuring Mohamad Mohty.